Columbia University researchers have utilized "base editing" to precisely modify human embryo DNA, successfully avoiding the significant chromosomal damage seen with traditional CRISPR. While the study aims to prevent inherited diseases, it highlights critical safety challenges like mosaicism and reignites intense ethical debates regarding the long-term implications of genetic modification.